Skip to main content
University of Wisconsin-Madison

Wani lecture highlights historical anticancer discoveries

Pictured above, left-right: Dean Steven M. Swanson, Mansukh C. Wani, Ph.D., Principal Scientist Emeritus, Research Triangle Institute; A. Douglas Kinghorn, Ph.D., DSc, Professor; and Jack L. Beal Chair, Medicinal Chemistry and Pharmacognosy, The Ohio State University.
Pictured above, left-right: Dean Steven M. Swanson, Mansukh C. Wani, Ph.D., Principal Scientist Emeritus, Research Triangle Institute; A. Douglas Kinghorn, Ph.D., DSc, Professor; and Jack L. Beal Chair, Medicinal Chemistry and Pharmacognosy, The Ohio State University.

Dean Steven M. Swanson hosted Mansukh C. Wani, Ph.D., Principal Scientist Emeritus, Research Triangle Institute, who presented a lecture on The Discovery of Taxol and Camptothecin. Dr. Wani’s main areas of research have included the isolation and characterization of biologically active natural products and synthesis of anticancer and antifertility agents. In the area of natural products research at RTI, he has been involved in the isolation, purification, and characterization of a wide variety of antineoplastic agents including camptothecin and taxol. These extremely important leads have contributed to the development of four prescription drugs (irinotecan and topotecan from camptothecin, and paclitaxel and docetaxel from Taxol), which together accounted for about one-third of the total cancer chemotherapeutic agent market in 2002. In addition to this ongoing work on plant-derived antitumor agents, continuing efforts have also been directed towards the synthesis of potent water-soluble camptothecin analogs. He has published extensively with over 200 publications and 36 patents to his credit. He has been an invited speaker to a number of national and international symposia on taxol and camptothecin.

Dr. Wani is the recipient of many awards, including the Bruce F. Cain Memorial Award given by the American Association for Cancer Research, the City of Medicine Award given by the Greater Durham Chamber of Commerce, and the National Cancer Institute Award of Recognition, the 2000 Charles F. Kettering Prize of the General Motors Cancer Research Foundation, the Ranbaxy Research Award from the Ranbaxy Science Foundation, and the 2003 Distinguished Alumni Award from Indiana University.

In August 2002, a plaque commemorating the discovery of Taxol at RTI was unveiled by the Gifford Pinchot National Forest of Washington State, and in April 2003, the American Chemical Society designated the discovery of camptothecin and Taxol at RTI a National Historic Chemical Landmark. In 2005, Dr. Wani received the North Carolina Award in Science from the Governor of North Carolina. In 2008, Dr. Wani received the Paul Ehrlich Magic Bullet Lifetime Achievement Award.

View booklet: The Discovery of Camptothecin and Taxol (PDF)